As shown in Figs. 3A–3F, high expression levels of CCL2, CCL4, CCL21, CD200, CXCR3, and IGSF6 were significantly associated with improved survival in neuroblastoma patients (all p < 0.001). Here, IGSF6 is linked to neuroblastoma.